跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91 条关于
“Vandria”
全部
91
临床试验
37
药物
11
机构
16
资讯
27
去年
Vandria Doses First Subjects in Phase 1 Trial of VNA-318 for Neurodegenerative Diseases
9个月前
Vandria's VNA-318 Shows Promising Phase 1 Results with Novel Dual-Action Mechanism for Alzheimer's Disease
去年
FDA Rejects Vanda Pharmaceuticals' Fanapt for Gastroparesis
2年前
Guselkumab (Tremfya) Approved for Ulcerative Colitis: Expanding IBD Treatment Options
去年
Vanda Pharmaceuticals Battles FDA Over Gastroparesis Drug Hearing Delays
去年
Vanda Pharmaceuticals Reports Revenue Increase and Advances Pipeline in Q3 2024
9个月前
Avandra Health Acquires DatCard Systems and Sorna Corporation to Create World's Largest Medical Imaging Platform
去年
Vanda Pharmaceuticals Navigates Hetlioz Sales Decline with Expansion Efforts
11个月前
FDA Orphan Drug Director Sandra Retzky Reassigned Amid Inflation Reduction Act Policy Changes
上个月
Andrea Maier's Precision-Medicine Approach Aims to Give Longevity Science a Solid Evidence Base
第 1 页,共 3 页
上一页
下一页